{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:24:10Z","timestamp":1794533050118,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,13]],"date-time":"2018-05-13T00:00:00Z","timestamp":1526169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01EO1002"],"award-info":[{"award-number":["FKZ 01EO1002"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2050-9","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T10:06:58Z","timestamp":1526033218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia"],"prefix":"10.1186","volume":"22","author":[{"name":"for the MEDUSA study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Thomas-R\u00fcddel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Poidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,13]]},"reference":[{"issue":"Suppl 1","key":"2050_CR1","first-page":"S57","volume":"49","author":"P Maruna","year":"2000","unstructured":"Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(Suppl 1):S57\u201361.","journal-title":"Physiol Res"},{"issue":"1\u20132","key":"2050_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","volume":"323","author":"M Meisner","year":"2002","unstructured":"Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002;323(1\u20132):17\u201329.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2050_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426\u201335.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2050_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2050_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10238-012-0191-8","volume":"13","author":"H Brodska","year":"2012","unstructured":"Brodska H, Malickova K, Adamkova V, Benakova H, Stastna MM, Zima T. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2012;13(3):165\u201370.","journal-title":"Clin Exp Med"},{"issue":"7","key":"2050_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nm0712-999","volume":"18","author":"MW Moyer","year":"2012","unstructured":"Moyer MW. New biomarkers sought for improving sepsis management and care. Nat Med. 2012;18(7):999.","journal-title":"Nat Med"},{"key":"2050_CR7","first-page":"22","volume":"4","author":"NV Beloborodova","year":"2008","unstructured":"Beloborodova NV, Vostrikova T, Chernevskaia EA. Etiology of postoperative bacteremias in an intensive care unit: an association with the level of procalcitonin. Anesteziol Reanimatol. 2008;4:22\u20137.","journal-title":"Anesteziol Reanimatol"},{"key":"2050_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2334-8-38","volume":"8","author":"PE Charles","year":"2008","unstructured":"Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO, Blettery B. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38.","journal-title":"BMC Infect Dis"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"701480","DOI":"10.1155\/2015\/701480","volume":"2015","author":"C Leli","year":"2015","unstructured":"Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480.","journal-title":"Dis Markers"},{"issue":"44","key":"2050_CR10","doi-asserted-by":"publisher","first-page":"e1774","DOI":"10.1097\/MD.0000000000001774","volume":"94","author":"A Oussalah","year":"2015","unstructured":"Oussalah A, Ferrand J, Filhine-Tresarrieu P, Aissa N, Aimone-Gastin I, Namour F, Garcia M, Lozniewski A, Gueant JL. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article). Medicine (Baltimore). 2015;94(44):e1774.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2050_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos F, Ruddel H, Thomas-Ruddel D, Schwarzkopf D, Pausch C, Harbarth S, Schreiber T, Grundling M, Marshall J, Simon P, et al. Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med. 2017;43(11):1602\u201312.","journal-title":"Intensive Care Med"},{"issue":"2","key":"2050_CR12","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos F, Thomas-Ruddel D, Ruddel H, Engel C, Schwarzkopf D, Marshall JC, Harbarth S, Simon P, Riessen R, Keh D, et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care. 2014;18(2):R42.","journal-title":"Crit Care"},{"issue":"1\u20132","key":"2050_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000069777","volume":"49","author":"B Kocazeybek","year":"2003","unstructured":"Kocazeybek B, Kucukoglu S, Oner YA. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy. 2003;49(1\u20132):76\u201384.","journal-title":"Chemotherapy"},{"issue":"6\u20137","key":"2050_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/00365548.2011.554855","volume":"43","author":"I Koivula","year":"2011","unstructured":"Koivula I, Hamalainen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis. 2011;43(6\u20137):471\u20138.","journal-title":"Scand J Infect Dis"},{"issue":"14","key":"2050_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2169\/internalmedicine.53.1785","volume":"53","author":"A Nakajima","year":"2014","unstructured":"Nakajima A, Yazawa J, Sugiki D, Mizuguchi M, Sagara H, Fujisiro M, Shibazaki M, Hitani A, To M, Haruki K. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens. Intern Med. 2014;53(14):1497\u2013503.","journal-title":"Intern Med"},{"issue":"6","key":"2050_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/MAJ.0000000000000477","volume":"349","author":"SY Guo","year":"2015","unstructured":"Guo SY, Zhou Y, Hu QF, Yao J, Wang H. Procalcitonin is a marker of Gram-negative bacteremia in patients with sepsis. Am J Med Sci. 2015;349(6):499\u2013504.","journal-title":"Am J Med Sci"},{"issue":"5","key":"2050_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00011-012-0439-5","volume":"61","author":"GN Matwiyoff","year":"2012","unstructured":"Matwiyoff GN, Prahl JD, Miller RJ, Carmichael JJ, Amundson DE, Seda G, Daheshia M. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res. 2012;61(5):401\u20139.","journal-title":"Inflamm Res"},{"issue":"3","key":"2050_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/cc6862","volume":"12","author":"H Gao","year":"2008","unstructured":"Gao H, Evans TW, Finney SJ. Bench-to-bedside review: sepsis, severe sepsis and septic shock\u2014does the nature of the infecting organism matter? Crit Care. 2008;12(3):213.","journal-title":"Crit Care"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-0-387-77383-4_37","volume-title":"Intensive Care Medicine: Annual Update 2008","author":"S Leaver","year":"2008","unstructured":"Leaver S, Burke Gaffney A, Evans TW. Gram-positive and Gram-negative sepsis: two disease entities? In: Vincent J-L, editor. Intensive Care Medicine: Annual Update 2008. New York: Springer; 2008. p. 395\u2013403."},{"issue":"10","key":"2050_CR20","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1128\/IAI.71.10.5803-5813.2003","volume":"71","author":"RJ Feezor","year":"2003","unstructured":"Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun. 2003;71(10):5803\u201313.","journal-title":"Infect Immun"},{"issue":"3","key":"2050_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cyto.2007.07.004","volume":"39","author":"MA Mohamed","year":"2007","unstructured":"Mohamed MA, Cunningham-Rundles S, Dean CR, Hammad TA, Nesin M. Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls. Cytokine. 2007;39(3):171\u20137.","journal-title":"Cytokine"},{"issue":"40","key":"2050_CR22","doi-asserted-by":"publisher","first-page":"37692","DOI":"10.1074\/jbc.M105927200","volume":"276","author":"F Re","year":"2001","unstructured":"Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001;276(40):37692\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"2050_CR23","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/cc8898","volume":"14","author":"R Abe","year":"2010","unstructured":"Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010;14(2):R27.","journal-title":"Crit Care"},{"issue":"3","key":"2050_CR24","first-page":"169","volume":"52","author":"C Prat","year":"2006","unstructured":"Prat C, Dominguez J, Andreo F, Blanco S, Pallares A, Cuchillo F, Ramil C, Ruiz-Manzano J, Ausina V. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. J Inf Secur. 2006;52(3):169\u201377.","journal-title":"J Inf Secur"},{"issue":"2","key":"2050_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cid\/cix317","volume":"65","author":"WH Self","year":"2017","unstructured":"Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, Waterer GW, Courtney DM, Bramley AM, Trabue C, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65(2):183\u201390.","journal-title":"Clin Infect Dis"},{"key":"2050_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2016.01.018","volume":"44","author":"S Wu","year":"2016","unstructured":"Wu S, Ma C, Gao X, Zhang L, Miao Q, Li M, Li W, Song X, Wang X, Liu J, et al. Group A Streptococcus induces less p65 nuclear translocation and non-classical nuclear factor kappa B activation in macrophages, which possibly leads to a weaker inflammatory response. Int J Infect Dis. 2016;44:50\u201360.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"2050_CR27","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1073\/pnas.0435928100","volume":"100","author":"R Malley","year":"2003","unstructured":"Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A. 2003;100(4):1966\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2050_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/cc2194","volume":"7","author":"JL Vincent","year":"2003","unstructured":"Vincent JL, Opal S, Torres A, Bonten M, Cohen J, Wunderink R. The PIRO concept: I is for infection. Crit Care. 2003;7(3):252\u20135.","journal-title":"Crit Care"},{"issue":"9","key":"2050_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1097\/CCM.0000000000000416","volume":"42","author":"TM Osborn","year":"2014","unstructured":"Osborn TM, Phillips G, Lemeshow S, Townsend S, Schorr CA, Levy MM, Dellinger RP. Sepsis severity score: an internationally derived scoring system from the surviving sepsis campaign database. Crit Care Med. 2014;42(9):1969\u201376.","journal-title":"Crit Care Med"},{"issue":"1","key":"2050_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/SHK.0000000000000566","volume":"46","author":"EA Choe","year":"2016","unstructured":"Choe EA, Shin TG, Jo IJ, Hwang SY, Lee TR, Cha WC, Sim MS. The prevalence and clinical significance of low procalcitonin levels among patients with severe sepsis or septic shock in the emergency department. Shock. 2016;46(1):37\u201343.","journal-title":"Shock"},{"issue":"4","key":"2050_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/SHK.0b013e318188c273","volume":"31","author":"G Andonegui","year":"2009","unstructured":"Andonegui G, Goring K, Liu D, McCafferty DM, Winston BW. Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: an experimental mouse model of gram-positive sepsis. Shock. 2009;31(4):423\u20138.","journal-title":"Shock"},{"issue":"6","key":"2050_CR32","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/cc9328","volume":"14","author":"C van Nieuwkoop","year":"2010","unstructured":"van Nieuwkoop C, Bonten TN, van't Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14(6):R206.","journal-title":"Crit Care"},{"key":"2050_CR33","volume-title":"Transkriptomik der Inflammation an der Maus: die Lunge als Ausgangsorgan und als Zielorgan der Sepsis","author":"M Weber","year":"2010","unstructured":"Weber M. Transkriptomik der Inflammation an der Maus: die Lunge als Ausgangsorgan und als Zielorgan der Sepsis. Jena: Friedrich Schiller University; 2010."},{"key":"2050_CR34","first-page":"S38","volume":"43","author":"DO Thomas-Rueddel","year":"2015","unstructured":"Thomas-Rueddel DO, Poidinger B, Eiche J, Jelschen F, Kott M, Weiss M, Reinhart K, Bloos F. Influence of pathogen and focus of infection on procalcitonin values in bacteremic severe sepsis. Infection. 2015;43:S38\u20139.","journal-title":"Infection"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2050-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T18:00:17Z","timestamp":1557770417000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2050-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2050-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,13]]},"assertion":[{"value":"25 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original trial whose dataset was analyzed was approved by the local ethics committees at each participating institution and by the responsible state data protection boards. The need for informed consent was waived by all committees and data protection boards. The main vote was by the ethics committee of the University Hospital Jena (2910-08\/10). A list of all involved ethical bodies is supplied as Additional\u00a0file\u00a0. No ethics approval was necessary for this secondary analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"128"}}